Certificate of Analysis
Third-party analytical testing report for research purposes only
CP-COA-2509-3585
REP-2025-19822
Sample Information
Compound
Healing Research Stack
Batch / Lot
CP-2509-3585
CAS Number
N/A
Label Claim
20 mg
Date Received
2025-09-17
Date Tested
2025-09-20
Date Issued
2025-09-23
Storage
Store at -20°C. Protect from light and moisture.
Appearance
White lyophilized powder, clear glass vial with aluminum crimp seal
Testing Laboratory
SGS Life Science Services
Rue du Marchais 3, 1020 Renens, Switzerland
Method
Visual QC
Analytical Results
ALL TESTS PASS
All analytical parameters meet or exceed acceptance criteria.
Analytical Data
Healing Research Stack — Batch CP-2509-3585
HPLC-UV Chromatogram
Retention Time
5.772 min
Peak Area
15678 mAU·s
Wavelength
214 nm
Chromatographic Purity
99.4%
Methods & Authorization
Healing Research Stack — Batch CP-2509-3585
Analytical Methods
USP <621>
Purity and potency determined by reversed-phase high-performance liquid chromatography (RP-HPLC) with UV detection at 214 nm and electrospray ionization mass spectrometry (ESI-MS) for identity confirmation. A C18 column (4.6 x 150 mm, 5 µm) was used with a linear gradient of water and acetonitrile, both containing 0.1% trifluoroacetic acid (TFA). Flow rate: 1.0 mL/min. Column temperature: 25°C. Injection volume: 10 µL.
USP <85>
Bacterial endotoxins test performed using the Limulus Amebocyte Lysate (LAL) kinetic turbidimetric method. Sensitivity: 0.01 EU/mL. Standard curve range: 0.01–1.0 EU/mL. Positive product control (PPC) spike recovery: 50–200%. All controls within acceptance criteria.
USP <61>
Microbial enumeration (bioburden) determined by membrane filtration per USP <61>. Total Aerobic Microbial Count (TAMC) on Soybean-Casein Digest Agar incubated at 30–35°C for 3–5 days. Total Yeast and Mold Count (TYMC) on Sabouraud Dextrose Agar incubated at 20–25°C for 5–7 days.
USP <630>
Visual inspection of physical appearance, color, and form. Sample compared against reference description for the active pharmaceutical ingredient.
Authorization
Dr. Henrik Lindqvist, Ph.D.
Analyst
Signed digitally on 2025-09-23
Dr. Elena Konstantinova, Ph.D.
Laboratory Director
Signed digitally on 2025-09-23
DISCLAIMER: This Certificate of Analysis is provided for research and informational purposes only. The products described herein are intended solely for in-vitro research and laboratory use. They are not intended for human or veterinary use, food, cosmetic, or household applications. The analytical data reported in this document pertains only to the specific batch/lot identified above and should not be extrapolated to other batches. CertaPeptides (CERTALAB S.R.L.) makes no warranties regarding the fitness of these products for any particular purpose beyond research applications. Results are valid for the batch number specified. Verify authenticity at certapeptides.com/verify.